* Mesa Laboratories Inc MLAB.OQ reported a quarterly
adjusted
loss of 39 cents per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was
for earnings of 42 cents per share.
* Revenue rose 60.1% to $54.70 million from a year ago;
analysts
expected $44.47 million.
* Mesa Laboratories Inc's reported EPS for the quarter was a
loss
of 39 cents.
* The mean earnings estimate of analysts had risen by
about 2.4%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Mesa Laboratories Inc shares had fallen by 14.8% this
quarter.
* The company reported a quarterly loss of $2.06 million.
* Wall Street's median 12-month price target for Mesa
Laboratories
Inc is $320.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
This summary was machine generated February 3 at 03:43 p.m.
All figures in US dollars unless otherwise stated